Last edition
News about "partial-onset seizures"
Lupin Limited Secures US FDA Approval for Generic Brivaracetam Oral Solution
Lupin has received US FDA approval for its generic brivaracetam oral solution, bioequivalent to Briviact, and has launched the product in the US market targeting partial-onset seizures.
Partial-onset Seizures | 25/02/2026 | By News Bureau | 148
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members